Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

5W5J

Identification of potent and selective RIPK2 inhibitors for the treatment of inflammatory diseases

Summary for 5W5J
Entry DOI10.2210/pdb5w5j/pdb
Related5W5W
DescriptorReceptor-interacting serine/threonine-protein kinase 2, N-(2-chlorophenyl)pyrazolo[1,5-a]pyridine-3-carboxamide, SULFATE ION, ... (4 entities in total)
Functional Keywordsinhibitor, complex, kinase, hydrolase, hydrolase-hydrolase inhibitor complex, hydrolase/hydrolase inhibitor
Biological sourceHomo sapiens (Human)
Cellular locationCytoplasm : O43353
Total number of polymer chains2
Total formula weight72079.41
Authors
Kreusch, A.,Spraggon, G. (deposition date: 2017-06-15, release date: 2017-10-25, Last modification date: 2024-04-03)
Primary citationHe, X.,Da Ros, S.,Nelson, J.,Zhu, X.,Jiang, T.,Okram, B.,Jiang, S.,Michellys, P.Y.,Iskandar, M.,Espinola, S.,Jia, Y.,Bursulaya, B.,Kreusch, A.,Gao, M.Y.,Spraggon, G.,Baaten, J.,Clemmer, L.,Meeusen, S.,Huang, D.,Hill, R.,Nguyen-Tran, V.,Fathman, J.,Liu, B.,Tuntland, T.,Gordon, P.,Hollenbeck, T.,Ng, K.,Shi, J.,Bordone, L.,Liu, H.
Identification of Potent and Selective RIPK2 Inhibitors for the Treatment of Inflammatory Diseases.
ACS Med Chem Lett, 8:1048-1053, 2017
Cited by
PubMed: 29057049
DOI: 10.1021/acsmedchemlett.7b00258
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.85 Å)
Structure validation

218500

數據於2024-04-17公開中

PDB statisticsPDBj update infoContact PDBjnumon